Economic evaluation of sunitinib versus pazopanib and best supportive care for the treatment of metastatic renal cell carcinoma in Chile: cost-effectiveness analysis and a mixed treatment comparison

Publisher:
Informa UK Limited
Publication Type:
Journal Article
Citation:
Expert Review of Pharmacoeconomics & Outcomes Research, 2019
Issue Date:
2019
Metrics:
Full metadata record
Files in This Item:
Filename Description Size
cv_expert_rev_pharmacoecon_outcomes_res.pdfAccepted Manuscript Version1.35 MB
Adobe PDF
Please use this identifier to cite or link to this item: